Severe infusion reaction due to nivolumab: A case report-Reference-Cited by-同舟云学术

Severe infusion reaction due to nivolumab: A case report

Published:2020-05-04 Issue:3 Volume:3 Page:
ISSN:2573-8348
Container-title:CANCER REPORTS
language:en
Short-container-title:Cancer Reports

Author:

Kumari Seema¹²^ORCID,Yun James³⁴,Soares James R.⁵,Ding Pei N.¹⁴

Affiliation:

1. Medical Oncology DepartmentNepean Hospital Cancer Care Centre Kingswood New South Wales Australia

2. Medical Oncology DepartmentWestmead Hospital Crown Princess Mary Cancer Centre Westmead New South Wales Australia

3. Clinical Immunology and AllergyNepean Hospital Kingswood New South Wales Australia

4. The University of Sydney Camperdown New South Wales Australia

5. Intensive Care UnitNepean Hospital Kingswood New South Wales Australia

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1246

Reference9 articles.

1. OPDIVO (nivolumab) Label‐ FDA.pdf [Internet];2018. [revised 2018 April cited November 14 2019].https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125554s058lbl.pdf.

2. Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy

3. National Clinical Guideline Centre (UK). Drug allergy: diagnosis and management of drug allergy in adults children and young people. London: National Institute for Health and Care Excellence (UK); 2014 September. (NICE Clinical Guidelines No. 183)Vol. 7 Measuring serum tryptase after suspected anaphylaxis.https://www.ncbi.nlm.nih.gov/books/NBK274147/.

4. Nivolumab infusion reaction manifesting as plantar erythema and pulmonary infiltrate in a lung cancer patient

5. First case of allergy to nivolumab

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction;Frontiers in Oncology;2024-03-04

2. Management of infusion-related reactions in cancer therapy: strategies and challenges;ESMO Open;2024-03

3. Acquired angioedema late in the course of nivolumab treatment;Journal of Oncology Pharmacy Practice;2023-04-17

4. A Non-small Cell Lung Cancer Patient Who Was Successfully Resuscitated After Cardiac Arrest Caused by Infusion-related Reaction with Carboplatin, Paclitaxel, Nivolumab, and Ipilimumab Therapy;Haigan;2022-12-20

5. Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors—A Systematic Review of the Literature;Current Oncology;2022-12-02